A Comprehensive Review of Bioinformatics Tools for Genomic Biomarker Discovery Driving Precision Oncology
Genes · 06.08.2024 · 15 (8) · 1036
DOI: 10.3390/genes15081036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 06.08.2024. Verfasst von Alexis J Clark und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms, Computational Biology, Precision Medicine. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Chan Zuckerberg Initiative, NIH HHS.
Abstract (Originalsprache)
The rapid advancement of high-throughput technologies, particularly next-generation sequencing (NGS), has revolutionized cancer research by enabling the investigation of genetic variations such as SNPs, copy number variations, gene expression, and protein levels. These technologies have elevated the significance of precision oncology, creating a demand for biomarker identification and validation. This review explores the complex interplay of oncology, cancer biology, and bioinformatics tools, highlighting the challenges in statistical learning, experimental validation, data processing, and quality control that underpin this transformative field. This review outlines the methodologies and applications of bioinformatics tools in cancer genomics research, encompassing tools for data structuring, pathway analysis, network analysis, tools for analyzing biomarker signatures, somatic variant interpretation, genomic data analysis, and visualization tools. Open-source tools and repositories like The Cancer Genome Atlas (TCGA), Genomic Data Commons (GDC), cBioPortal, UCSC Genome Browser, Array Express, and Gene Expression Omnibus (GEO) have emerged to streamline cancer omics data analysis. Bioinformatics has significantly impacted cancer research, uncovering novel biomarkers, driver mutations, oncogenic pathways, and therapeutic targets. Integrating multi-omics data, network analysis, and advanced ML will be pivotal in future biomarker discovery and patient prognosis prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
ORCID-Profile: Alexis J Clark
Förderung
- NCI NIH HHS
- Chan Zuckerberg Initiative
- NIH HHS
- NIGMS NIH HHS
- MSM/TU/UABCCC
- National Institute of General Medical Sciences
- Chan Zuckerberg Initiative: Accelerate Precision Health Program
Zitieren
APA
Clark, A. J., & Lillard, J. W. (2024). A Comprehensive Review of Bioinformatics Tools for Genomic Biomarker Discovery Driving Precision Oncology. Genes, 15(8), 1036. https://doi.org/10.3390/genes15081036
Vancouver
Clark AJ, Lillard JW. A Comprehensive Review of Bioinformatics Tools for Genomic Biomarker Discovery Driving Precision Oncology. Genes. 2024;15(8):1036. doi:10.3390/genes15081036
BibTeX
@article{Clark2024,
author = {Clark, Alexis J and Lillard, James W},
title = {A Comprehensive Review of Bioinformatics Tools for Genomic Biomarker Discovery Driving Precision Oncology},
journal = {Genes},
year = {2024},
volume = {15},
number = {8},
pages = {1036},
doi = {10.3390/genes15081036}
}
EUVIMED